Ledger.Open graph →
SEC Form D · filed October 26, 2020

Aridis Pharmaceuticals, Inc

Offering
$8.4M
Sold
$8.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Jose, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

John K. Hamilton · San Jose, CADirectorEric Patzer · San Jose, CAExec · DirectorCraig K. Gibbs · San Jose, CADirectorRobert R. Ruffolo, Jr · San Jose, CADirectorVu Troung · San Jose, CAExec · DirectorSusan Windham-Bannister · San Jose, CADirectorNasiba Hartland-Mackie · Dallas, TXDirectorMamadou S. Diallo · Pasadena, CADirectorBradley Messmer · San Diego, CADirectorKe Cheng · Raleigh, NCExec · DirectorTim M. Flynn · Riverside, CAExec · DirectorMike Nazak · San Jose, CAExecNeil Senturia · San Diego, CADirectorRichard D. Carlson · Gainesville, FLExec · DirectorBernie Breton · Denver, CODirectorElizabeth C. Williamson · Chicago, ILDirectorSusan W. Stevens · PORTLAND, ORExec · DirectorMike Nazak · San Jose, CAExecSusan Windham-Bannister · San Jose, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗